Why the Life Science Industry Should Care About the Proposed HTI-2 Rule
By Kim Boyd – In an era where data fluidity is transforming healthcare, life sciences manufacturers must stay attuned to evolving Health IT policies given that many of these policies have downstream effects on life sciences and access to expanded deidentified and aggregated datasets.
Read More